Pearl ML - Search Results

1

Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).

Miller DS, Filiaci VL, Mannel RS, Cohn DE, Matsumoto T, Tewari KS, DiSilvestro P, Pearl ML, Argenta PA, Powell MA, Zweizig SL, Warshal DP, Hanjani P, Carney ME, Huang H, Cella D, Zaino R, Fleming GF. Miller DS, et al. Among authors: pearl ml. J Clin Oncol. 2020 Nov 20;38(33):3841-3850. doi: 10.1200/JCO.20.01076. Epub 2020 Sep 29. J Clin Oncol. 2020. PMID: 33078978 Free PMC article. Clinical Trial.

2

Absence of cumulative bone marrow suppression in heavily pretreated ovarian cancer patients undergoing salvage chemotherapy with paclitaxel.

Pearl ML, Johnston CM, Reynolds RK, Roberts JA. Pearl ML, et al. Oncology. 1995 Sep-Oct;52(5):407-12. doi: 10.1159/000227498. Oncology. 1995. PMID: 7543668

3

A randomized controlled trial of a regular diet as the first meal in gynecologic oncology patients undergoing intraabdominal surgery.

Pearl ML, Frandina M, Mahler L, Valea FA, DiSilvestro PA, Chalas E. Pearl ML, et al. Obstet Gynecol. 2002 Aug;100(2):230-4. doi: 10.1016/s0029-7844(02)02067-7. Obstet Gynecol. 2002. PMID: 12151142 Clinical Trial.

4

Comparison of tolerance of combination carboplatin and paclitaxel chemotherapy by age in women with ovarian cancer.

Villella JA, Chaudhry T, Pearl ML, Valea F, DiSilvestro PA, Pollack S, Chalas E. Villella JA, et al. Among authors: pearl ml. Gynecol Oncol. 2002 Sep;86(3):316-22. doi: 10.1006/gyno.2002.6781. Gynecol Oncol. 2002. PMID: 12217754

5

Outcomes of endometrial cancer patients undergoing surgery with gynecologic oncology involvement.

Pearl ML, Villella JA, Valea FA, DiSilvestro PA, Chalas E. Pearl ML, et al. Obstet Gynecol. 2002 Oct;100(4):724-9. doi: 10.1016/s0029-7844(02)02089-6. Obstet Gynecol. 2002. PMID: 12383541

6

Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomas.

Pearl ML, Inagami M, McCauley DL, Valea FA, Chalas E, Fischer M. Pearl ML, et al. Int J Gynecol Cancer. 2002 Nov-Dec;12(6):745-8. doi: 10.1046/j.1525-1438.2002.01139.x. Int J Gynecol Cancer. 2002. PMID: 12445253

7

Panniculectomy in morbidly obese gynecologic oncology patients.

Pearl ML, Valea FA, Disilvestro PA, Chalas E. Pearl ML, et al. Int J Surg Investig. 2000;2(1):59-64. Int J Surg Investig. 2000. PMID: 12774339

8

Pilot phase 2 trial of 4 months of maintenance pegylated liposomal Doxorubicin in patients with advanced ovarian cancer after complete response to platinum and Paclitaxel-based chemotherapy.

DiSilvestro PA, Fisher M, Pearl ML, Buhl A, Chalas E, Valea FA. DiSilvestro PA, et al. Among authors: pearl ml. Gynecol Obstet Invest. 2007;63(1):1-6. doi: 10.1159/000094361. Epub 2006 Jun 30. Gynecol Obstet Invest. 2007. PMID: 16809933 Clinical Trial.

9

A phase II study of weekly docetaxel for patients with advanced or recurrent cancer of the cervix.

Pearl ML, Johnston CM, McMeekin DS. Pearl ML, et al. Gynecol Obstet Invest. 2007;64(4):193-8. doi: 10.1159/000106489. Epub 2007 Jul 30. Gynecol Obstet Invest. 2007. PMID: 17664880 Clinical Trial.

10

Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

Kavanagh JJ, Sill MW, Ramirez PT, Warshal D, Pearl ML, Morgan MA. Kavanagh JJ, et al. Among authors: pearl ml. Int J Gynecol Cancer. 2008 May-Jun;18(3):460-4. doi: 10.1111/j.1525-1438.2007.01053.x. Epub 2007 Sep 13. Int J Gynecol Cancer. 2008. PMID: 17854432 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page